Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New anesthesia drug may keep blood pressure more stable during robotic surgery

NCT ID NCT07251101

Knowledge-focused Sponsor: Ilsan Cha hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two anesthesia drugs—remimazolam and propofol—to see which one keeps blood pressure more stable during robot-assisted gynecologic surgery. 58 women under 65 will be randomly assigned to receive one of the drugs. The main goal is to measure blood pressure throughout the procedure. This is an early-stage trial that may help guide future anesthesia choices.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
remimazolam and propofol
What this could lead to
If remimazolam proves better at maintaining blood pressure, it could become a preferred anesthetic for robotic surgeries.
What could go wrong
This is a small, early-phase study (58 people) comparing two existing drugs, so results may not change practice. No major risks beyond standard anesthesia.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 58 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Up to 65 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female patients \<65 years of age * American Society of Anesthesiologists (ASA) physical status I-II * Scheduled to undergo robotic hysterectomy under general anesthesia Exclusion Criteria: * Body mass index (BMI) \> 35 kg/m² * Baseline hypotension (systolic blood pressure \<100 mmHg) or bradycardia (heart rate \<60 bpm) * History of ischemic heart disease or cardiac conduction block * Significant cardiopulmonary disease, including hypoxemia (SpO₂ \<90%), uncontrolled asthma, or chronic obstructive pulmonary disease (COPD) * Use of inhalational anesthetics during anesthesia * Conversion from robotic/laparoscopic surgery to open laparotomy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anesthesia, intravenous are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Pneumoperitoneum

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anesthesia, intravenous Gynecologic surgery Hemodynamic stability

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHA Ilsan Medical Center

    Goyang-si, Gyeonggi-do, 10414, South Korea

  • CHA Ilsan Medical Center

    Goyang-si, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.